Radosław Kołodziej
Radosław Kołodziej has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Anna Kołodziej
Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland
10 shared publications - Emilia Kucab
University Clinical Hospital F. Chopin in Rzeszów, Rzeszów, Poland
10 shared publications - Izabella Kula
City Hospital of John Paul II in Rzeszów, Rzeszów, Poland
10 shared publications - Jakub Klecha
Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland
10 shared publications - Joanna CiemięGa
University of Rzeszow, Rzeszow, Poland
10 shared publications - Kacper Szpanelewski
Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland
10 shared publications
Latest Publications
- Open Access
- 22 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
ATRIAL FIBRILLATION, WEARABLE TECHNOLOGIES AND ARTIFICIAL INTELLIGENCE: CURRENT EVIDENCE, CLINICAL UTILITY AND LIMITATIONS
Background: Atrial fibrillation is the most common sustained cardiac arrhythmia in adults and represents an important clinical and public health problem because of its association with stroke, mortality, disability, and healthcare burden. Its paroxysmal and frequently asymptomatic course limits the effectiveness of conventional diagnostic strategies based on occasional electrocardiographic recordings. Aim: This narrative review aims to summarise current evidence regarding the use of wearable technologies and artificial intelligence for the detection of atrial fibrillation, with particular emphasis on diagnostic accuracy, clinical utility, and principal limitations. Methods: A structured literature search was performed using PubMed, Scopus, Web of Science, and Google Scholar. Studies published between 2021 and 2026 were primarily considered. Search terms included “atrial fibrillation,” “wearable technologies,” “smartwatch,” “electrocardiography,” “photoplethysmography,” “artificial intelligence,” “machine learning,” and “diagnostics.” Priority was given to original studies, systematic reviews, meta-analyses, and clinically relevant review articles concerning wearable devices, artificial intelligence, and atrial fibrillation detection. Earlier landmark studies were included when they were necessary to explain key evidence discussed in recent reviews and meta-analyses. Results: Wearable devices such as smartwatches, fitness bands, and portable ECG systems allow longer heart rhythm monitoring in daily life and may help detect paroxysmal and clinically silent atrial fibrillation. ECG-based devices are more consistent with current diagnostic standards, whereas photoplethysmography-based systems are more accessible and can provide passive rhythm monitoring. Artificial intelligence, especially machine learning and deep learning, can support signal interpretation, arrhythmia recognition, and risk prediction. However, diagnostic performance reported in controlled studies may not always translate directly into real-world clinical practice. Conclusions: Wearable technologies and artificial intelligence offer a promising way to support atrial fibrillation screening and monitoring. They may improve early detection, especially in asymptomatic individuals, but should not replace standard diagnostic methods. Photoplethysmography-based alerts should be regarded as screening signals, while a final diagnosis of atrial fibrillation should still be confirmed by ECG in an appropriate clinical context. More large-scale studies are needed before these tools can be widely implemented in routine practice.
- 22 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
Open AccessATRIAL FIBRILLATION, WEARABLE TECHNOLOGIES AND ARTIFICIAL INTELLIGENCE: CURRENT EVIDENCE, CLINICAL UTILITY AND LIMITATIONS
Background: Atrial fibrillation is the most common sustained cardiac arrhythmia in adults and represents an important clinical and public health problem because of its association with stroke, mortality, disability, and healthcare burden. Its paroxysmal and frequently asymptomatic course limits the effectiveness of conventional diagnostic strategies based on occasional electrocardiographic recordings. Aim: This narrative review aims to summarise current evidence regarding the use of wearable technologies and artificial intelligence for the detection of atrial fibrillation, with particular emphasis on diagnostic accuracy, clinical utility, and principal limitations. Methods: A structured literature search was performed using PubMed, Scopus, Web of Science, and Google Scholar. Studies published between 2021 and 2026 were primarily considered. Search terms included “atrial fibrillation,” “wearable technologies,” “smartwatch,” “electrocardiography,” “photoplethysmography,” “artificial intelligence,” “machine learning,” and “diagnostics.” Priority was given to original studies, systematic reviews, meta-analyses, and clinically relevant review articles concerning wearable devices, artificial intelligence, and atrial fibrillation detection. Earlier landmark studies were included when they were necessary to explain key evidence discussed in recent reviews and meta-analyses. Results: Wearable devices such as smartwatches, fitness bands, and portable ECG systems allow longer heart rhythm monitoring in daily life and may help detect paroxysmal and clinically silent atrial fibrillation. ECG-based devices are more consistent with current diagnostic standards, whereas photoplethysmography-based systems are more accessible and can provide passive rhythm monitoring. Artificial intelligence, especially machine learning and deep learning, can support signal interpretation, arrhythmia recognition, and risk prediction. However, diagnostic performance reported in controlled studies may not always translate directly into real-world clinical practice. Conclusions: Wearable technologies and artificial intelligence offer a promising way to support atrial fibrillation screening and monitoring. They may improve early detection, especially in asymptomatic individuals, but should not replace standard diagnostic methods. Photoplethysmography-based alerts should be regarded as screening signals, while a final diagnosis of atrial fibrillation should still be confirmed by ECG in an appropriate clinical context. More large-scale studies are needed before these tools can be widely implemented in routine practice.
- Open Access
- 22 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
THE BIDIRECTIONAL RELATIONSHIP BETWEEN INSOMNIA AND DEPRESSION IN THE DIGITAL AGE: A STRUCTURED NARRATIVE REVIEW
Introduction: Insomnia and depression are common psychiatric conditions that significantly impact global health. Recent evidence shows a bidirectional relationship between these disorders, influenced by lifestyle changes and widespread digital technology use. Objective: This structured narrative review analyzes the two -way relationship between insomnia and depression in the digital period, focusing on neurobiological, behavioral, and technology -related mechanisms. Materials and Methods: We conducted a structured narrative review across PubMed, Scopus, and Web of Science. The review covered peer -reviewed longitudinal studies, systematic reviews, and meta -analyses published over the last 10 to 15 years that focused on digital behaviors such as screen time and social media use. Because the studies used different methods and reported different results, we used a qualitative synthesis. Results: According to the studies, depression and sleeplessness are tightly related. Depression frequently results in persistent sleep issues, such as poor quality sleep, difficulty falling asleep, and altered sleep patterns, and insomnia can increase the risk of depression. Similar elements, including abnormalities with the HPA axis, circadian rhythms, and neurotransmitters, link the two diseases. Sleep issues and an increased risk of depression are also linked to excessive use of internet -based platforms such as Instagram and TikTok. Conclusions: Insomnia and depression are closely connected and can make each other worse through both biological and behavioral factors. Today, technology also has a big impact on this relationship. Spotting and treating sleep problems early, along with using technology responsibly, may help reduce the risk and severity of depression. Adding sleep -focused and technology -aware strategies to mental health care can lead to better results and help prevent problems.
- 22 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
Open AccessTHE BIDIRECTIONAL RELATIONSHIP BETWEEN INSOMNIA AND DEPRESSION IN THE DIGITAL AGE: A STRUCTURED NARRATIVE REVIEW
Introduction: Insomnia and depression are common psychiatric conditions that significantly impact global health. Recent evidence shows a bidirectional relationship between these disorders, influenced by lifestyle changes and widespread digital technology use. Objective: This structured narrative review analyzes the two -way relationship between insomnia and depression in the digital period, focusing on neurobiological, behavioral, and technology -related mechanisms. Materials and Methods: We conducted a structured narrative review across PubMed, Scopus, and Web of Science. The review covered peer -reviewed longitudinal studies, systematic reviews, and meta -analyses published over the last 10 to 15 years that focused on digital behaviors such as screen time and social media use. Because the studies used different methods and reported different results, we used a qualitative synthesis. Results: According to the studies, depression and sleeplessness are tightly related. Depression frequently results in persistent sleep issues, such as poor quality sleep, difficulty falling asleep, and altered sleep patterns, and insomnia can increase the risk of depression. Similar elements, including abnormalities with the HPA axis, circadian rhythms, and neurotransmitters, link the two diseases. Sleep issues and an increased risk of depression are also linked to excessive use of internet -based platforms such as Instagram and TikTok. Conclusions: Insomnia and depression are closely connected and can make each other worse through both biological and behavioral factors. Today, technology also has a big impact on this relationship. Spotting and treating sleep problems early, along with using technology responsibly, may help reduce the risk and severity of depression. Adding sleep -focused and technology -aware strategies to mental health care can lead to better results and help prevent problems.
- Open Access
- 25 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
ADVANCES AND CHALLENGES IN CONTINUOUS GLUCOSE MONITORING FOR DIABETES MANAGEMENT. A NARRATIVE REVIEW
Diabetes mellitus is a major challenge for global health. It is characterized by rising prevalence, often delayed diagnosis, and significant clinical and economic burden. During the last two decades, Continuous Glucose Monitoring systems have become one of the most important developments in the management of DM. In this short review, we will describe the importance of the research on CGM systems, their advantages over previously available monitoring methods, as well as their limitations that still need to be addressed by manufacturers and physicians managing patients' treatment. We also dedicate a section of this article to newly emerging solutions, including insulin therapy with CGMs as a base and new directions in CGM applications across the medical field.
- 25 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessADVANCES AND CHALLENGES IN CONTINUOUS GLUCOSE MONITORING FOR DIABETES MANAGEMENT. A NARRATIVE REVIEW
Diabetes mellitus is a major challenge for global health. It is characterized by rising prevalence, often delayed diagnosis, and significant clinical and economic burden. During the last two decades, Continuous Glucose Monitoring systems have become one of the most important developments in the management of DM. In this short review, we will describe the importance of the research on CGM systems, their advantages over previously available monitoring methods, as well as their limitations that still need to be addressed by manufacturers and physicians managing patients' treatment. We also dedicate a section of this article to newly emerging solutions, including insulin therapy with CGMs as a base and new directions in CGM applications across the medical field.
- Open Access
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
THE ROLE OF PAIN AS A RESPIRATORY STIMULANT: A CASE REPORT OF SUDDEN RESPIRATORY DEPRESSION FOLLOWING REGIONAL ANESTHESIA IN A PATIENT ON HIGH-DOSE OXYCODONE
This study provides a detailed case report of a 65-year-old patient with disseminated cancer who was receiving extremely high doses of oxycodone (2 g/day) for severe, uncontrolled pain. A suprascapular nerve block with bupivacaine provided almost immediate relief; however, after 25 minutes, it led to sudden respiratory arrest. This event necessitated urgent emergency medical intervention and ICU hospitalization. Clinical analysis ruled out local anesthetic systemic toxicity (LAST), identifying the physiological antagonism between nociception and the respiratory depressive effects of opioids as the cause. Pain, acting as a natural respiratory stimulant, masked the effects of severe oxycodone overdose. The block's analgesic effect abruptly removed this stimulus, resulting in apnea. The article discusses the underlying mechanisms and provides a differential diagnosis between tolerance and opioid-induced hyperalgesia (OIH). It emphasizes the importance of multimodal treatment, including ultra-low-dose naloxone, to prevent dose escalation. The findings indicate a critical need for hospitalizing patients requiring high analgesic doses for safe titration and the necessity of intensive monitoring during regional anesthesia in opioid-dependent individuals. Introduction: The aim of this paper is to present and analyze a rare but life-threatening complication: respiratory arrest following local anesthesia in an oncology patient receiving extremely high doses of opioids. The work highlights the physiological role of pain as an antagonist of opioid-induced respiratory depression. Methodology: A case of a 65-year-old male with disseminated cancer, treated with an extremely high dose of oxycodone (2 g/day), is described. Due to severe shoulder pain, a suprascapular nerve block was performed using 5 ml of 0.5% bupivacaine and methylprednisolone. A literature review was conducted to differentiate the causes of apnea, including the exclusion of Local Anesthetic Systemic Toxicity (LAST). Results: Pain subsided almost immediately following the procedure; however, after 25 minutes, the patient experienced sudden apnea requiring intubation and ICU hospitalization. Analysis excluded technical error and systemic toxicity (LAST) based on dosage and symptom dynamics. The most likely cause was the elimination of the painful stimulus, which previously stimulated the respiratory center and balanced the depressive effects of high-dose oxycodone.
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
Open AccessTHE ROLE OF PAIN AS A RESPIRATORY STIMULANT: A CASE REPORT OF SUDDEN RESPIRATORY DEPRESSION FOLLOWING REGIONAL ANESTHESIA IN A PATIENT ON HIGH-DOSE OXYCODONE
This study provides a detailed case report of a 65-year-old patient with disseminated cancer who was receiving extremely high doses of oxycodone (2 g/day) for severe, uncontrolled pain. A suprascapular nerve block with bupivacaine provided almost immediate relief; however, after 25 minutes, it led to sudden respiratory arrest. This event necessitated urgent emergency medical intervention and ICU hospitalization. Clinical analysis ruled out local anesthetic systemic toxicity (LAST), identifying the physiological antagonism between nociception and the respiratory depressive effects of opioids as the cause. Pain, acting as a natural respiratory stimulant, masked the effects of severe oxycodone overdose. The block's analgesic effect abruptly removed this stimulus, resulting in apnea. The article discusses the underlying mechanisms and provides a differential diagnosis between tolerance and opioid-induced hyperalgesia (OIH). It emphasizes the importance of multimodal treatment, including ultra-low-dose naloxone, to prevent dose escalation. The findings indicate a critical need for hospitalizing patients requiring high analgesic doses for safe titration and the necessity of intensive monitoring during regional anesthesia in opioid-dependent individuals. Introduction: The aim of this paper is to present and analyze a rare but life-threatening complication: respiratory arrest following local anesthesia in an oncology patient receiving extremely high doses of opioids. The work highlights the physiological role of pain as an antagonist of opioid-induced respiratory depression. Methodology: A case of a 65-year-old male with disseminated cancer, treated with an extremely high dose of oxycodone (2 g/day), is described. Due to severe shoulder pain, a suprascapular nerve block was performed using 5 ml of 0.5% bupivacaine and methylprednisolone. A literature review was conducted to differentiate the causes of apnea, including the exclusion of Local Anesthetic Systemic Toxicity (LAST). Results: Pain subsided almost immediately following the procedure; however, after 25 minutes, the patient experienced sudden apnea requiring intubation and ICU hospitalization. Analysis excluded technical error and systemic toxicity (LAST) based on dosage and symptom dynamics. The most likely cause was the elimination of the painful stimulus, which previously stimulated the respiratory center and balanced the depressive effects of high-dose oxycodone.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
THE POCKET LABORATORY IN PRACTICE: A SOCIO-TECHNICAL REVIEW OF SMARTPHONE-BASED POINT-OF-CARE DIAGNOSTICS IN LMICs
Background: Infectious diseases remain a leading cause of mortality in low- and middle-income countries (LMICs), where nearly half the global population lacks adequate access to diagnostics. Smartphone-based point-of-care (POC) diagnostic technologies have emerged as a promising response to this gap, leveraging the rapid expansion of mobile phone ownership across resource-limited settings. However, a critical disconnect persists between the pace of technological innovation and the complex socio-technical realities of deploying such tools in resource-limited settings. Objective: This narrative review synthesizes the literature on smartphone-based POC diagnostics for infectious diseases in LMICs, adopting a socio-technical systems perspective that extends beyond analytical performance to examine the human, organizational, and contextual determinants of implementation success. Methods: A narrative review was conducted drawing on PubMed, Scopus, Web of Science, Google Scholar, and grey literature from WHO and partner agencies. The analysis was guided by a socio-technical systems framework and WHO’s REASSURED criteria for evaluating point-of-care diagnostic readiness. Results: The review identifies four principal technological approaches — imaging-based, sensor-based, molecular, and data-driven diagnostics — and evaluates them against the WHO REASSURED criteria. Three models of task shifting to community health workers are proposed, each carrying distinct implications for training, governance, and quality assurance. Five categories of last-mile barriers are documented: infrastructural, regulatory, socio-cultural, economic, and technological. While proof-of-concept evidence is abundant, real-world implementation data from scaled programs remain scarce. The persistent gap between technological capability and population-level health impact is attributable not to engineering deficits but to systemic implementation failures. Conclusions: Transitioning from pilot projects to sustainable, nationally integrated diagnostic programs requires coordinated action across regulatory harmonization, workforce development, user-centered design, and domestic financing — a shift from technology-centric to socio-technical approaches.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessTHE POCKET LABORATORY IN PRACTICE: A SOCIO-TECHNICAL REVIEW OF SMARTPHONE-BASED POINT-OF-CARE DIAGNOSTICS IN LMICs
Background: Infectious diseases remain a leading cause of mortality in low- and middle-income countries (LMICs), where nearly half the global population lacks adequate access to diagnostics. Smartphone-based point-of-care (POC) diagnostic technologies have emerged as a promising response to this gap, leveraging the rapid expansion of mobile phone ownership across resource-limited settings. However, a critical disconnect persists between the pace of technological innovation and the complex socio-technical realities of deploying such tools in resource-limited settings. Objective: This narrative review synthesizes the literature on smartphone-based POC diagnostics for infectious diseases in LMICs, adopting a socio-technical systems perspective that extends beyond analytical performance to examine the human, organizational, and contextual determinants of implementation success. Methods: A narrative review was conducted drawing on PubMed, Scopus, Web of Science, Google Scholar, and grey literature from WHO and partner agencies. The analysis was guided by a socio-technical systems framework and WHO’s REASSURED criteria for evaluating point-of-care diagnostic readiness. Results: The review identifies four principal technological approaches — imaging-based, sensor-based, molecular, and data-driven diagnostics — and evaluates them against the WHO REASSURED criteria. Three models of task shifting to community health workers are proposed, each carrying distinct implications for training, governance, and quality assurance. Five categories of last-mile barriers are documented: infrastructural, regulatory, socio-cultural, economic, and technological. While proof-of-concept evidence is abundant, real-world implementation data from scaled programs remain scarce. The persistent gap between technological capability and population-level health impact is attributable not to engineering deficits but to systemic implementation failures. Conclusions: Transitioning from pilot projects to sustainable, nationally integrated diagnostic programs requires coordinated action across regulatory harmonization, workforce development, user-centered design, and domestic financing — a shift from technology-centric to socio-technical approaches.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
BIOPSYCHOSOCIAL BURDEN OF IRRITABLE BOWEL SYNDROME: A NARRATIVE REVIEW OF QUALITY OF LIFE, MENTAL HEALTH AND DIGITAL HEALTH PERSPECTIVES
Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction characterized by recurrent abdominal pain associated with altered bowel habits in the absence of structural abnormalities that could fully explain the reported symptoms. Despite the lack of organic lesions typical of structural gastrointestinal diseases, IBS remains a significant diagnostic and therapeutic challenge because of its heterogeneous clinical presentation, multifactorial pathogenesis, and substantial impact on patients’ quality of life. The aim of this review was to summarize current evidence regarding epidemiology, pathogenesis, clinical presentation, diagnosis, treatment, and quality-of-life burden associated with IBS. Particular attention was paid to the variability in prevalence estimates depending on diagnostic criteria and study methodology, as well as to the role of the gut-brain axis, gut microbiota, visceral hypersensitivity, immune activation, and psychosocial factors in the development and persistence of symptoms. The review also highlights the importance of a positive diagnostic strategy based on Rome IV criteria, identification of alarm features, and selective use of additional tests. Current therapeutic approaches require individualized and integrated management that combines patient education, dietary interventions, psychological therapies, and symptom-directed pharmacological treatment. IBS does not increase mortality; however, it markedly impairs social, occupational, and emotional functioning. A multidimensional, biopsychosocial approach therefore appears essential for improving both symptom control and overall patient well-being.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessBIOPSYCHOSOCIAL BURDEN OF IRRITABLE BOWEL SYNDROME: A NARRATIVE REVIEW OF QUALITY OF LIFE, MENTAL HEALTH AND DIGITAL HEALTH PERSPECTIVES
Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction characterized by recurrent abdominal pain associated with altered bowel habits in the absence of structural abnormalities that could fully explain the reported symptoms. Despite the lack of organic lesions typical of structural gastrointestinal diseases, IBS remains a significant diagnostic and therapeutic challenge because of its heterogeneous clinical presentation, multifactorial pathogenesis, and substantial impact on patients’ quality of life. The aim of this review was to summarize current evidence regarding epidemiology, pathogenesis, clinical presentation, diagnosis, treatment, and quality-of-life burden associated with IBS. Particular attention was paid to the variability in prevalence estimates depending on diagnostic criteria and study methodology, as well as to the role of the gut-brain axis, gut microbiota, visceral hypersensitivity, immune activation, and psychosocial factors in the development and persistence of symptoms. The review also highlights the importance of a positive diagnostic strategy based on Rome IV criteria, identification of alarm features, and selective use of additional tests. Current therapeutic approaches require individualized and integrated management that combines patient education, dietary interventions, psychological therapies, and symptom-directed pharmacological treatment. IBS does not increase mortality; however, it markedly impairs social, occupational, and emotional functioning. A multidimensional, biopsychosocial approach therefore appears essential for improving both symptom control and overall patient well-being.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
PLATELET-RICH PLASMA VERSUS HYALURONIC ACID IN THE TREATMENT OF PAIN ASSOCIATED WITH KNEE OSTEOARTHRITIS: A NARRATIVE REVIEW OF CURRENT EVIDENCE
Introduction: Osteoarthritis of the knee (gonarthrosis) is one of the most common causes of chronic pain and disability in adults and the elderly. In recent years, there has been growing interest in biological treatment methods, including platelet-rich plasma (PRP) injections, which contain growth factors that can stimulate regenerative processes and modulate inflammation. Viscosupplementation with hyaluronic acid also remains a commonly used method. Objective: The aim of this study was to analyze current data on the effectiveness of PRP in the treatment of pain in gonarthrosis and to compare its effects with hyaluronic acid therapy. Materials and Methods: A literature review was conducted, including randomized clinical trials, meta-analyses, and systematic reviews on the use of PRP and hyaluronic acid in the treatment of knee osteoarthritis. Recent publications and key fundamental studies were included. Results: Both PRP and hyaluronic acid demonstrate effectiveness in reducing pain and improving joint function in knee osteoarthritis. However, numerous studies directly comparing the two treatments indicate that PRP is more effective, particularly at longer follow-up. For example, PRP therapy is associated with a greater reduction in pain on the VAS scale and greater improvements in WOMAC and IKDC scores than hyaluronic acid. The enhanced effects of PRP are most notable in patients with early- and moderate-stage disease. Conclusions: PRP is a beneficial treatment option for knee osteoarthritis and, based on current comparative studies, may offer more durable symptom improvement than hyaluronic acid. However, further research is necessary to standardize treatment protocols and confirm long-term comparative effectiveness.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessPLATELET-RICH PLASMA VERSUS HYALURONIC ACID IN THE TREATMENT OF PAIN ASSOCIATED WITH KNEE OSTEOARTHRITIS: A NARRATIVE REVIEW OF CURRENT EVIDENCE
Introduction: Osteoarthritis of the knee (gonarthrosis) is one of the most common causes of chronic pain and disability in adults and the elderly. In recent years, there has been growing interest in biological treatment methods, including platelet-rich plasma (PRP) injections, which contain growth factors that can stimulate regenerative processes and modulate inflammation. Viscosupplementation with hyaluronic acid also remains a commonly used method. Objective: The aim of this study was to analyze current data on the effectiveness of PRP in the treatment of pain in gonarthrosis and to compare its effects with hyaluronic acid therapy. Materials and Methods: A literature review was conducted, including randomized clinical trials, meta-analyses, and systematic reviews on the use of PRP and hyaluronic acid in the treatment of knee osteoarthritis. Recent publications and key fundamental studies were included. Results: Both PRP and hyaluronic acid demonstrate effectiveness in reducing pain and improving joint function in knee osteoarthritis. However, numerous studies directly comparing the two treatments indicate that PRP is more effective, particularly at longer follow-up. For example, PRP therapy is associated with a greater reduction in pain on the VAS scale and greater improvements in WOMAC and IKDC scores than hyaluronic acid. The enhanced effects of PRP are most notable in patients with early- and moderate-stage disease. Conclusions: PRP is a beneficial treatment option for knee osteoarthritis and, based on current comparative studies, may offer more durable symptom improvement than hyaluronic acid. However, further research is necessary to standardize treatment protocols and confirm long-term comparative effectiveness.
- Open Access
- 29 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
SEIZURE DETECTION DEVICES IN THE HOME ENVIRONMENT: A LONG SEARCH FOR LIFE-SAVING SOLUTIONS
A reliable seizure detection device (SDD) in an ambulatory/home environment has been a much-needed solution. Benefits of developing such a device would include: improving Quality of Life (QoL) for patients and their caregivers; providing more information to physicians caring for these patients (which, in turn, could help adjust medication); and possibly reducing the risk of Sudden Unexpected Death from Epilepsy (SUDEP). However, searching for it has proven difficult. This short narrative review aims to: (1) introduce the reader to this particular field of study: its importance,scope, and problems; (2) show methods and technologies currently in use, recent developments in seizure detection devices - especially wearables, and new, less invasive solutions based on EEG; (3) discuss possible new approaches and emerging solutions.
- 29 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
Open AccessSEIZURE DETECTION DEVICES IN THE HOME ENVIRONMENT: A LONG SEARCH FOR LIFE-SAVING SOLUTIONS
A reliable seizure detection device (SDD) in an ambulatory/home environment has been a much-needed solution. Benefits of developing such a device would include: improving Quality of Life (QoL) for patients and their caregivers; providing more information to physicians caring for these patients (which, in turn, could help adjust medication); and possibly reducing the risk of Sudden Unexpected Death from Epilepsy (SUDEP). However, searching for it has proven difficult. This short narrative review aims to: (1) introduce the reader to this particular field of study: its importance,scope, and problems; (2) show methods and technologies currently in use, recent developments in seizure detection devices - especially wearables, and new, less invasive solutions based on EEG; (3) discuss possible new approaches and emerging solutions.
- Open Access
- 25 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
DIGITAL PHENOTYPING IN SCHIZOPHRENIA: CLINICAL APPLICATIONS, ETHICAL CHALLENGES, AND SOCIETAL IMPLICATIONS. A COMPREHENSIVE REVIEW
"Digital phenotyping" refers to the real-time measurement of human behavior using data from cellphones and wearable sensors. Interest in this method has increased in psychiatric research, particularly for severe mental disorders such as schizophrenia. Schizophrenia is a chronic illness that impairs daily functioning and is characterized by disturbances in perception, cognition, and emotional regulation. Traditional clinical evaluations are episodic and rely on self-reported data, potentially overlooking significant changes between visits. Digital phenotyping allows for continuous behavioral data collection in real-world settings, capturing metrics such as social interaction, communication, sleep, and mobility. These data can enhance understanding of symptom progression, relapse risk, and treatment effectiveness. However, digital monitoring raises ethical and social concerns regarding data governance, privacy, and the responsible use of artificial intelligence in psychiatric care. This review assesses the clinical value, technological foundations, and ethical considerations of digital phenotyping in schizophrenia. The article summarizes current research and proposes strategies for integrating digital behavioral monitoring into mental health care.
- 25 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
Open AccessDIGITAL PHENOTYPING IN SCHIZOPHRENIA: CLINICAL APPLICATIONS, ETHICAL CHALLENGES, AND SOCIETAL IMPLICATIONS. A COMPREHENSIVE REVIEW
"Digital phenotyping" refers to the real-time measurement of human behavior using data from cellphones and wearable sensors. Interest in this method has increased in psychiatric research, particularly for severe mental disorders such as schizophrenia. Schizophrenia is a chronic illness that impairs daily functioning and is characterized by disturbances in perception, cognition, and emotional regulation. Traditional clinical evaluations are episodic and rely on self-reported data, potentially overlooking significant changes between visits. Digital phenotyping allows for continuous behavioral data collection in real-world settings, capturing metrics such as social interaction, communication, sleep, and mobility. These data can enhance understanding of symptom progression, relapse risk, and treatment effectiveness. However, digital monitoring raises ethical and social concerns regarding data governance, privacy, and the responsible use of artificial intelligence in psychiatric care. This review assesses the clinical value, technological foundations, and ethical considerations of digital phenotyping in schizophrenia. The article summarizes current research and proposes strategies for integrating digital behavioral monitoring into mental health care.
- Open Access
- 22 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
VITAMIN D SUPPLEMENTATION IN PRIMARY DYSMENORRHEA. A NARRATIVE REVIEW
Primary dysmenorrhea (PD) is a frequent gynecological disorder that leads to repeated episodes of severe, cramping pain in the lower abdomen without any detectable pelvic pathology. It significantly reduces the quality of life and limits daily functioning in menstruating women. The main cause of PD is the excessive production of uterine prostaglandins, which results in stronger myometrial contractions, decreased blood flow to the uterus, and pain. Some recent studies have shown that vitamin D may be involved in regulating these processes due to its anti-inflammatory properties and ability to modulate prostaglandin synthesis. The objective of this review is to investigate the effect of vitamin D supplementation on the pain associated with primary dysmenorrhea. A literature search was conducted in PubMed and Google Scholar, focusing on clinical trials published within the last 15 years. The reviewed studies included randomized controlled trials of both high-dose and weekly vitamin D supplementation regimens. The results show that vitamin D supplementation can have a significant effect on reducing the pain intensity, duration of symptoms, and the consumption of analgesics, particularly in women with vitamin D deficiency. Alleviation of systemic symptoms such as headache, nausea/vomiting, fatigue, and diarrhea was also reported. Interestingly, the level of clinical improvement was not always directly proportional to the increase in serum vitamin D levels. Both short-term and long-term supplementation, as well as combination therapies with other agents such as vitamin E and ginger were effective. To sum up, vitamin D supplementation is possibly a new adjuvant therapy in the treatment of primary dysmenorrhea. However, more studies involving a larger number of participants are needed to determine the correct dosing and to verify its effectiveness in diverse populations.
- 22 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
Open AccessVITAMIN D SUPPLEMENTATION IN PRIMARY DYSMENORRHEA. A NARRATIVE REVIEW
Primary dysmenorrhea (PD) is a frequent gynecological disorder that leads to repeated episodes of severe, cramping pain in the lower abdomen without any detectable pelvic pathology. It significantly reduces the quality of life and limits daily functioning in menstruating women. The main cause of PD is the excessive production of uterine prostaglandins, which results in stronger myometrial contractions, decreased blood flow to the uterus, and pain. Some recent studies have shown that vitamin D may be involved in regulating these processes due to its anti-inflammatory properties and ability to modulate prostaglandin synthesis. The objective of this review is to investigate the effect of vitamin D supplementation on the pain associated with primary dysmenorrhea. A literature search was conducted in PubMed and Google Scholar, focusing on clinical trials published within the last 15 years. The reviewed studies included randomized controlled trials of both high-dose and weekly vitamin D supplementation regimens. The results show that vitamin D supplementation can have a significant effect on reducing the pain intensity, duration of symptoms, and the consumption of analgesics, particularly in women with vitamin D deficiency. Alleviation of systemic symptoms such as headache, nausea/vomiting, fatigue, and diarrhea was also reported. Interestingly, the level of clinical improvement was not always directly proportional to the increase in serum vitamin D levels. Both short-term and long-term supplementation, as well as combination therapies with other agents such as vitamin E and ginger were effective. To sum up, vitamin D supplementation is possibly a new adjuvant therapy in the treatment of primary dysmenorrhea. However, more studies involving a larger number of participants are needed to determine the correct dosing and to verify its effectiveness in diverse populations.